LYCOS RETRIEVER 
Celebrex: Drug Administration
built 673 days ago
Celecoxib was developed by G. D. Searle & Company and co-promoted by Monsanto (parent company of Searle) and Pfizer under the brand name Celebrex. Monsanto merged with Pharmacia, from which the Medical Research Division was acquired by Pfizer, giving Pfizer ownership of Celebrex. The drug was at the core of a major patent dispute that was resolved in Searle's favor (later Pfizer) in 2004. In University of Rochester v. G.D. Searle & Co., 358 F.3d 916 (Fed. Cir.
Source:
The boxed warning for all non-steroidal anti-inflammatory drugs (NSAIDs), including Celebrex, will ... contain information regarding gastrointestinal risk that is already included elsewhere in their current labels. In addition, the FDA is asking manufacturers of all over-the-counter NSAIDs to revise their labeling to include more information on the cardiovascular and gastrointestinal risks as well as a warning about potential skin reactions.
Source:
Since its approval by the FDA in 1998, over 27 million patients have taken the prescription drug Celebrex (Celecoxib). This non-steroidal anti-inflammatory drug is used to treat painful medical conditions such as osteoarthritis, arthritis, and adult rheumatoid arthritis.
Source:
If you are currently taking, or have taken, the drug Celebrex, you may be at risk for serious medical problems. If you or a loved one has suffered serious medical problems due to the use of the drug Celebrex, please contact a Celebrex lawyer at Bisnar | Chase to discuss your case.
MORE ABOUT
Drug Administration